Analyst Viewpoint
Unhygienic toilet habits coupled with unhealthy dietary habits are driving the anal fistula treatment market growth. Fast-paced lifestyles have led people to ignore their eating patterns, thereby resulting in increased consumption of junk food. Moreover, rise in sexually transmitted diseases (STDs) is driving the demand for anal fistula treatment.
Surgical procedures are the primary course of treatment of anal fistula. However, various minimally invasive, non-invasive, and oral medications are available even for those patients who are not able to withstand the pain post-surgery or whose anal fistula is not severe enough to be treated surgically. Availability of various methods of treatment for anal fistula is also expected to drive the anal fistula treatment market during the forecast period.
Anal fistula treatment involves connecting an infected cavity or abscess in the anal cavity to the outer skin in order to drain pus from the infected area. Perianal abscess therapy is generally the first course of treatment, wherein a complementary colostomy is advised by surgeons. However, the patient needs to be febrile, elderly, hypotensive, or have noteworthy comorbidities.
In other cases, surgical fistula correction could be replaced with minimally invasive fistula treatment that could encompass treatment through lasers. Herbal medicines could also be applied as per the directions of healthcare personnel. Fistulectomy procedure involves removal of fistula tract for promoting healing and preventing recurrence. Rectal fistula management is recommended for patients who are not able to bear the pain of surgical operations.
However, lack of awareness regarding the importance of anal fistula treatment in developing economies of Asia Pacific and MEA is likely to restrain the anal fistula treatment market revenue during the forecast period.
The frequency of anal fistula is increasing in people aged between 20 and 40. This is attributed to rise in Crohn’s disease among the population in the same age group. Sedentary lifestyles have led to a rise in intake of processed foods; especially meat and the other foods that contain saturated fats. Irritable bowel syndrome is a major consequence; however, ignoring it may culminate into Crohn’s disease.
The WHO states that more than 1 million sexually transmitted infections (STIs) are recorded worldwide every year, with majority of them being asymptomatic. People with multiple sex partners are at a higher risk of anal fistula. Growing occurrences of Crohn’s disease and STDs is expected to drive the market for anal fistula repair during the forecast period.
Rise in demand for effective treatments with almost no recurrence is prompting key players to introduce cutting-edge medications as well as equipment. Latest advancements in laser anal fistula treatment include minimally invasive technique wherein a radial fiber emits laser beam into fistula track, thereby resulting in shrinkage of tissue so that fistula gets sealed. An endorectal flap is used for closing of internal opening.
An advanced version of minimally invasive anal fistula treatment options is that of treatment through fibrin glue that implies surgeon injecting glue into fistula while the patient is under the influence of a general anesthetic. This glue helps in sealing fistula.
Surgical treatment of anal fistula happens better through holistic approach to post-surgery anal fistula treatment. Medical practitioners recommend consumption of fiber-rich foods and plenty of water, which would result in cultivation of proper bowel habits. Innovative herbal remedies for anal fistula treatment include intake of a tablespoon of honey or flaxseed in a glass filled with lukewarm water and application of coconut oil or Oregano oil to anal sphincter. Combining medications for effective anal fistula treatment include combining drainage Seton procedures and LIFT-plug. Availability of various modes of treatment is expected to drive the anal fistula treatment market demand during the forecast period.
Significantly high patient population suffering from inflammatory bowel diseases, increase in expenditure on healthcare, and introduction of novel therapies for treatment are key factors that are likely to drive the anal fistula treatment market share held by North America in the next few years. According to Mayo Clinic 2022 report, Mayo Clinic surgeons treat over 1,000 people suffering from anal fistulas every year worldwide.
As per research conducted by scientists at the University of Nottingham and sponsored by Crohn’s & Colitis UK and Coeliac UK, in 2022, 1 in every 123 people across the U.K. suffers either from ulcerative colitis or Crohn’s disease. This adds up to almost half a million population in the U.K. suffering from inflammatory bowel disease (IBD). Need to treat these ailments is expected to projected to boost the anal fistula treatment industry in Europe during the forecast period.
As per the latest anal fistula treatment industry analysis, leading players in the global market are following the latest anal fistula treatment market trends and investing significantly in clinical trials to develop innovative treatment techniques to minimize pain and recurrence associated with anal fistula surgical procedures. Prominent companies are also focusing on expansion of their product portfolio to consolidate their global presence.
Aditya Birla Chemicals Ltd., Kemira Oyj, Akzo Nobel NV, Evonik Industries AG, Merck & Co. Inc., Arkema S.A., Solvay SA, The Dow Chemical Company, Hawkins, Inc., and Spartan Chemical Company, Inc. are a few prominent entities operating in the global market.
Key players in anal fistula treatment market report have been profiled based on various parameters such as company overview, business strategies, financial overview, product portfolio, and business segments.
Attribute | Detail |
---|---|
Size in 2022 | US$ 650.9 Mn |
Forecast (Value) in 2031 | US$ 920.2 Mn |
Growth Rate (CAGR) | 3.8% |
Forecast Period | 2023-2031 |
Historical Data Available for | 2017-2021 |
Quantitative Units | US$ Mn for Value |
Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
Competition Landscape |
|
Format | Electronic (PDF) + Excel |
Anal Fistula Treatment Market Segmentation |
|
Regions Covered |
|
Countries Covered |
|
Companies Profiled |
|
Customization Scope | Available Upon Request |
Pricing | Available Upon Request |
The global market was valued at US$ 650.9 Mn in 2022
It is projected to expand at a CAGR of 3.8% from 2023 to 2031
Increase in incidence of Crohn’s Disease and STDs and rise in demand for safe and effective treatment with negligible recurrence
In terms of end-user, the hospitals and ambulatory surgical centers (ASCs) segment held largest share in 2022
North America is estimated to dominate in the next few years
Becton, Dickinson and Company, Biolitec AG, Cook Medical, Gem srl, KARL STORZ SE & Co. KG, Medtronic plc, TiGenix NV, and W.L. Gore & Associates, Inc. (Gore Medical)
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Anal Fistula Treatment Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Anal Fistula Treatment Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Anal Fistula Treatment Market Analysis and Forecast, by Treatment Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Treatment Type, 2017–2031
6.3.1. Non-surgical
6.3.1.1. Drugs
6.3.1.2. Others (fibrin glue, adipose stem cell therapy, etc.)
6.3.2. Surgical
6.3.2.1. Fistulotomy
6.3.2.2. Bioprosthetic Plus
6.3.2.3. Advancement Flap Procedures
6.3.2.4. Seton Techniques
6.3.2.5. Others
6.4. Market Attractiveness Analysis, by Treatment Type
7. Global Anal Fistula Treatment Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Application, 2017–2031
7.3.1. Intersphincteric
7.3.2. Transsphincteric
7.3.3. Suprasphincteric
7.3.4. Extrasphincteric
7.3.5. Others
7.4. Market Attractiveness Analysis, by Application
8. Global Anal Fistula Treatment Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Hospitals & Ambulatory Surgical Centers
8.3.2. Clinics
8.3.3. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global Anal Fistula Treatment Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2017–2031
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Anal Fistula Treatment Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Treatment Type, 2017–2031
10.3.1. Non-surgical
10.3.1.1. Drugs
10.3.1.2. Others (fibrin glue, adipose stem cell therapy, etc.)
10.3.2. Surgical
10.3.2.1. Fistulotomy
10.3.2.2. Bioprosthetic Plus
10.3.2.3. Advancement Flap Procedures
10.3.2.4. Seton Techniques
10.3.2.5. Others
10.4. Market Value Forecast, by Application, 2017–2031
10.4.1. Intersphincteric
10.4.2. Transsphincteric
10.4.3. Suprasphincteric
10.4.4. Extrasphincteric
10.4.5. Others
10.5. Market Value Forecast, by End-user, 2017–2031
10.5.1. Hospitals & Ambulatory Surgical Centers
10.5.2. Clinics
10.5.3. Others
10.6. Market Value Forecast, by Country, 2017–2031
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Treatment Type
10.7.2. By Application
10.7.3. By End-user
10.7.4. By Country
11. Europe Anal Fistula Treatment Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Treatment Type, 2017–2031
11.3.1. Non-surgical
11.3.1.1. Drugs
11.3.1.2. Others (fibrin glue, adipose stem cell therapy, etc.)
11.3.2. Surgical
11.3.2.1. Fistulotomy
11.3.2.2. Bioprosthetic Plus
11.3.2.3. Advancement Flap Procedures
11.3.2.4. Seton Techniques
11.3.2.5. Others
11.4. Market Value Forecast, by Application, 2017–2031
11.4.1. Intersphincteric
11.4.2. Transsphincteric
11.4.3. Suprasphincteric
11.4.4. Extrasphincteric
11.4.5. Others
11.5. Market Value Forecast, by End-user, 2017–2031
11.5.1. Hospitals & Ambulatory Surgical Centers
11.5.2. Clinics
11.5.3. Others
11.6. Market Value Forecast, by Country/Sub-region, 2017–2031
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Treatment Type
11.7.2. By Application
11.7.3. By End-user
11.7.4. By Country/Sub-region
12. Asia Pacific Anal Fistula Treatment Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Treatment Type, 2017–2031
12.3.1. Non-surgical
12.3.1.1. Drugs
12.3.1.2. Others (fibrin glue, adipose stem cell therapy, etc.)
12.3.2. Surgical
12.3.2.1. Fistulotomy
12.3.2.2. Bioprosthetic Plus
12.3.2.3. Advancement Flap Procedures
12.3.2.4. Seton Techniques
12.3.2.5. Others
12.4. Market Value Forecast, by Application, 2017–2031
12.4.1. Intersphincteric
12.4.2. Transsphincteric
12.4.3. Suprasphincteric
12.4.4. Extrasphincteric
12.4.5. Others
12.5. Market Value Forecast, by End-user, 2017–2031
12.5.1. Hospitals & Ambulatory Surgical Centers
12.5.2. Clinics
12.5.3. Others
12.6. Market Value Forecast, by Country/Sub-region, 2017–2031
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. By Treatment Type
12.7.2. By Application
12.7.3. By End-user
12.7.4. By Country/Sub-region
13. Latin America Anal Fistula Treatment Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Treatment Type, 2017–2031
13.3.1. Non-surgical
13.3.1.1. Drugs
13.3.1.2. Others (fibrin glue, adipose stem cell therapy, etc.)
13.3.2. Surgical
13.3.2.1. Fistulotomy
13.3.2.2. Bioprosthetic Plus
13.3.2.3. Advancement Flap Procedures
13.3.2.4. Seton Techniques
13.3.2.5. Others
13.4. Market Value Forecast, by Application, 2017–2031
13.4.1. Intersphincteric
13.4.2. Transsphincteric
13.4.3. Suprasphincteric
13.4.4. Extrasphincteric
13.4.5. Others
13.5. Market Value Forecast, by End-user, 2017–2031
13.5.1. Hospitals & Ambulatory Surgical Centers
13.5.2. Clinics
13.5.3. Others
13.6. Market Value Forecast, by Country/Sub-region, 2017–2031
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Treatment Type
13.7.2. By Application
13.7.3. By End-user
13.7.4. By Country/Sub-region
14. Middle East & Africa Anal Fistula Treatment Market Analysis and Forecast
14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Treatment Type, 2017–2031
14.3.1. Non-surgical
14.3.1.1. Drugs
14.3.1.2. Others (fibrin glue, adipose stem cell therapy, etc.)
14.3.2. Surgical
14.3.2.1. Fistulotomy
14.3.2.2. Bioprosthetic Plus
14.3.2.3. Advancement Flap Procedures
14.3.2.4. Seton Techniques
14.3.2.5. Others
14.4. Market Value Forecast, by Application, 2017–2031
14.4.1. Intersphincteric
14.4.2. Transsphincteric
14.4.3. Suprasphincteric
14.4.4. Extrasphincteric
14.4.5. Others
14.5. Market Value Forecast, by End-user, 2017–2031
14.5.1. Hospitals & Ambulatory Surgical Centers
14.5.2. Clinics
14.5.3. Others
14.6. Market Value Forecast, by Country/Sub-region, 2017–2031
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. By Treatment Type
14.7.2. By Application
14.7.3. By End-user
14.7.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2022)
15.3. Company Profiles
15.3.1. Becton, Dickinson and Company
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. Biolitec AG
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. Cook Medical
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. Gem srl
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. KARL STORZ SE & Co. KG
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. Medtronic plc
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. TiGenix NV
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. W.L. Gore & Associates, Inc. (Gore Medical)
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
List of Tables
Table 01: Global Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2017–2031
Table 02: Global Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 03: Global Anal Fistula Treatment Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 04: Global Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Region, 2017–2031
Table 05: North America Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Country, 2017–2031
Table 06: North America Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2017–2031
Table 07: North America Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 08: North America Anal Fistula Treatment Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 09: Europe Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 10: Europe Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2017–2031
Table 11: Europe Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 12: Europe Anal Fistula Treatment Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 13: Asia Pacific Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 14: Asia Pacific Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2017–2031
Table 15: Asia Pacific Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 16: Asia Pacific Anal Fistula Treatment Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 17: Latin America Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 18: Latin America Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2017–2031
Table 19: Latin America Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 20: Latin America Anal Fistula Treatment Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 21: Middle East & Africa Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 22: Middle East & Africa Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2017–2031
Table 23: Middle East & Africa Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 24: Middle East & Africa Anal Fistula Treatment Market Size (US$ Mn) Forecast, by End-user, 2017–2031
List of Figures
Figure 01: Global Anal Fistula Treatment Market Size (US$ Mn) and Distribution (%), by Region, 2022 and 2031
Figure 02: Global Anal Fistula Treatment Market Revenue (US$ Mn), by Treatment Type, 2022
Figure 03: Global Anal Fistula Treatment Market Value Share, by Treatment Type, 2022
Figure 04: Global Anal Fistula Treatment Market Revenue (US$ Mn), by Application, 2022
Figure 05: Global Anal Fistula Treatment Market Value Share, by Application, 2022
Figure 06: Global Anal Fistula Treatment Market Revenue (US$ Mn), by End-user, 2022
Figure 07: Global Anal Fistula Treatment Market Value Share, by End-user, 2022
Figure 08: Global Anal Fistula Treatment Market Value Share, by Region, 2022
Figure 09: Global Anal Fistula Treatment Market Value (US$ Mn) Forecast, 2023–2031
Figure 10: Global Anal Fistula Treatment Market Value Share Analysis, by Treatment Type, 2022 and 2031
Figure 11: Global Anal Fistula Treatment Market Attractiveness Analysis, by Treatment Type, 2023-2031
Figure 12: Global Anal Fistula Treatment Market Value Share Analysis, by Application, 2022 and 2031
Figure 13: Global Anal Fistula Treatment Market Attractiveness Analysis, by Application, 2023-2031
Figure 14: Global Anal Fistula Treatment Market Value Share Analysis, by End-user, 2022 and 2031
Figure 15: Global Anal Fistula Treatment Market Attractiveness Analysis, by End-user, 2022-2031
Figure 16: Global Anal Fistula Treatment Market Value Share Analysis, by Region, 2022 and 2031
Figure 17: Global Anal Fistula Treatment Market Attractiveness Analysis, by Region, 2022-2031
Figure 18: North America Anal Fistula Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 19: North America Anal Fistula Treatment Market Attractiveness Analysis, by Country, 2023–2031
Figure 20: North America Anal Fistula Treatment Market Value Share Analysis, by Country, 2022 and 2031
Figure 21: North America Anal Fistula Treatment Market Value Share Analysis, by Treatment Type, 2022 and 2031
Figure 22: North America Anal Fistula Treatment Market Value Share Analysis, by Application, 2022 and 2031
Figure 23: North America Anal Fistula Treatment Market Value Share Analysis, by End-user, 2022 and 2031
Figure 24: North America Anal Fistula Treatment Market Attractiveness Analysis, by Treatment Type, 2023–2031
Figure 25: North America Anal Fistula Treatment Market Attractiveness Analysis, by Application, 2023–2031
Figure 26: North America Anal Fistula Treatment Market Attractiveness Analysis, by End-user, 2023–2031
Figure 27: Europe Anal Fistula Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 28: Europe Anal Fistula Treatment Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 29: Europe Anal Fistula Treatment Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 30: Europe Anal Fistula Treatment Market Value Share Analysis, by Treatment Type, 2022 and 2031
Figure 31: Europe Anal Fistula Treatment Market Value Share Analysis, by Application, 2022 and 2031
Figure 32: Europe Anal Fistula Treatment Market Value Share Analysis, by End-user, 2022 and 2031
Figure 33: Europe Anal Fistula Treatment Market Attractiveness Analysis, by Treatment Type, 2023–2031
Figure 34: Europe Anal Fistula Treatment Market Attractiveness Analysis, by Application, 2023–2031
Figure 35: Europe Anal Fistula Treatment Market Attractiveness Analysis, by End-user, 2023–2031
Figure 36: Asia Pacific Anal Fistula Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 37: Asia Pacific Anal Fistula Treatment Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 38: Asia Pacific Anal Fistula Treatment Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 39: Asia Pacific Anal Fistula Treatment Market Value Share Analysis, by Treatment Type, 2022 and 2031
Figure 40: Asia Pacific Anal Fistula Treatment Market Value Share Analysis, by Application, 2022 and 2031
Figure 41: Asia Pacific Anal Fistula Treatment Market Value Share Analysis, by End-user, 2022 and 2031
Figure 42: Asia Pacific Anal Fistula Treatment Market Attractiveness Analysis, by Treatment Type, 2023–2031
Figure 43: Asia Pacific Anal Fistula Treatment Market Attractiveness Analysis, by Application, 2023–2031
Figure 44: Asia Pacific Anal Fistula Treatment Market Attractiveness Analysis, by End-user, 2023–2031
Figure 45: Latin America Anal Fistula Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 46: Latin America Anal Fistula Treatment Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 47: Latin America Anal Fistula Treatment Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 48: Latin America Anal Fistula Treatment Market Value Share Analysis, by Treatment Type, 2022 and 2031
Figure 49: Latin America Anal Fistula Treatment Market Value Share Analysis, by Application, 2022 and 2031
Figure 50: Latin America Anal Fistula Treatment Market Value Share Analysis, by End-user, 2022 and 2031
Figure 51: Latin America Anal Fistula Treatment Market Attractiveness Analysis, by Treatment Type, 2023–2031
Figure 52: Latin America Anal Fistula Treatment Market Attractiveness Analysis, by Application, 2023–2031
Figure 53: Latin America Anal Fistula Treatment Market Attractiveness Analysis, by End-user, 2023–2031
Figure 54: Middle East & Africa Anal Fistula Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 55: Middle East & Africa Anal Fistula Treatment Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 56: Middle East & Africa Anal Fistula Treatment Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 57: Middle East & Africa Anal Fistula Treatment Market Value Share Analysis, by Treatment Type, 2022 and 2031
Figure 58: Middle East & Africa Anal Fistula Treatment Market Value Share Analysis, by Application, 2022 and 2031
Figure 59: Middle East & Africa Anal Fistula Treatment Market Value Share Analysis, by End-user, 2022 and 2031
Figure 60: Middle East & Africa Anal Fistula Treatment Market Attractiveness Analysis, by Treatment Type, 2023–2031
Figure 61: Middle East & Africa Anal Fistula Treatment Market Attractiveness Analysis, by Application, 2023–2031
Figure 62: Middle East & Africa Anal Fistula Treatment Market Attractiveness Analysis, by End-user, 2023–2031